Form 8-K - Current report:
SEC Accession No. 0001493152-20-022797
Filing Date
2020-12-02
Accepted
2020-12-01 20:51:04
Documents
2
Period of Report
2020-11-30
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8k.htm 8-K 31258
2 ex99-1.htm EX-99.1 8637
  Complete submission text file 0001493152-20-022797.txt   41085
Mailing Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733
Business Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733 310 203 2902
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Filer) CIK: 0001335105 (see all company filings)

EIN.: 202903526 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39717 | Film No.: 201362209
SIC: 2834 Pharmaceutical Preparations